Automatic Data Processing vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 80)

Automatic Data Processing

LeaderManufacturing

Enterprise

Roseland NJ payroll and HCM leader (NASDAQ: ADP) $19.2B FY2024 revenue (+7%); 1.1M clients, $55B+ float income, TotalSource PEO, ADP NER economic data competing with Paychex and Workday.

AI VisibilityBeta
Overall Score
A80
Category Rank
#254 of 290
AI Consensus
57%
Trend
stable
Per Platform
ChatGPT
91
Perplexity
81
Gemini
78

About

Automatic Data Processing, Inc. (ADP) is a Roseland, New Jersey-based payroll processing and human capital management company — publicly traded on the NASDAQ (NASDAQ: ADP) as an S&P 500 Information Technology component — providing payroll processing, tax administration, benefits administration, HR management, time and attendance, talent management, and retirement plan services to 1.1 million clients ranging from small businesses (1-49 employees) to large enterprises (1,000+ employees) through approximately 58,000 employees globally. In fiscal year 2024 (ending June 2024), ADP reported revenues of $19.2 billion (+7% year-over-year) and adjusted EPS of $9.14 (+12%), continuing the company's consistent mid-to-high single digit revenue growth and double-digit EPS growth from operating leverage and capital return. CEO Maria Black (appointed 2023, ADP's first female CEO, previously leading ADP's employer services division) leads ADP's strategy of deepening client platform engagement: ADP's "employer of record" (EOR) and professional employer organization (PEO — ADP TotalSource) services handle all payroll, HR compliance, and benefits administration for small and mid-size businesses — creating outsourcing relationships where ADP becomes the operational HR department for companies that lack internal HR expertise. ADP's client fund float (ADP holds $55+ billion in client payroll funds between the time employers fund payroll and ADP distributes payments to employees and tax authorities — a multi-day float period generating interest income on $55B at current interest rates) generated $1.6B+ in interest income in FY2024 as rates remained elevated, creating an earnings tailwind that amplifies ADP revenue growth during high-interest rate environments.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

80
Overall Score
90
#254
Category Rank
#9
57
AI Consensus
60
stable
Trend
stable
91
ChatGPT
99
81
Perplexity
99
78
Gemini
83
72
Claude
96
84
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.